ReviewFrontiers in surgery2026
Clinical importance of the persistent primitive hypoglossal artery in vascular lesions and endovascular treatment: a narrative review.
Review in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The persistent primitive hypoglossal artery (PPHA) is a rare and anatomically complex cerebrovascular variant. Although typically asymptomatic, its presence is associated with various cerebrovascular pathologies, including intracranial aneurysms, carotid artery stenosis, acute large vessel occlusion, moyamoya disease, brain arteriovenous malformations, and other vascular anomalies. When such lesions involve the PPHA, therapeutic intervention may be necessitated. Surgical management is particularly challenging due to the artery's deep anatomical location and intricate surrounding vasculature. Consequently, endovascular therapy (EVT) has emerged as a preferable alternative to open surgery, offering a favorable safety profile and reduced technical complexity. Despite this, a substantial need remains in the literature regarding systematic evaluations of the PPHA's clinical significance in vascular pathology and the efficacy of EVT. This review aims to address this need through a comprehensive narrative synthesis of available literature and clinical experience in managing these complex cases. This review found that when EVT is required, the PPHA can serve as an access route. However, given that it often provides the sole blood supply to the posterior circulation-particularly in the context of bilateral hypoplastic vertebral arteries-the vessel must be meticulously preserved during interventions for associated conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.